Tiziana Life Sciences Ltd (NASDAQ:TLSA) has a beta value of 0.39 and has seen 2.4 million shares traded in the last trading session. The company, currently valued at $187.02M, closed the last trade at $1.69 per share which meant it gained $0.19 on the day or 12.67% during that session. The TLSA stock price is -2.96% off its 52-week high price of $1.74 and 75.74% above the 52-week low of $0.41.
The consensus among analysts is that Tiziana Life Sciences Ltd (TLSA) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
Tiziana Life Sciences Ltd (NASDAQ:TLSA) trade information
Sporting 12.67% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the TLSA stock price touched $1.69 or saw a rise of 11.52%. Year-to-date, Tiziana Life Sciences Ltd shares have moved 142.75%, while the 5-day performance has seen it change 31.01%. Over the past 30 days, the shares of Tiziana Life Sciences Ltd (NASDAQ:TLSA) have changed 156.06%.
Tiziana Life Sciences Ltd (TLSA) estimates and forecasts
The company’s shares have gained 83.70% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -12.98% over the past 5 years.
TLSA Dividends
Tiziana Life Sciences Ltd is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Tiziana Life Sciences Ltd (NASDAQ:TLSA)’s Major holders
The top two institutional holders are ALPHAMARK ADVISORS, LLC with over 4589.0 shares worth more than $0.31 million. As of 2024-06-30, ALPHAMARK ADVISORS, LLC held 0.0045% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Nasdaq Composite Index ETF and Fidelity NASDAQ Composite Index Fund . As of Dec 31, 2024 , the former fund manager holds about 0.16% shares in the company for having 167.84 shares of worth $0.28 million while later fund manager owns 74.14 shares of worth $0.13 million as of Dec 31, 2024 , which makes it owner of about 0.07% of company’s outstanding stock.
